| MMP14 expression in CAFs at the TSI (biopsies) | MMP14 expression in the tumour nest at the TSI (biopsies) | MMP14 co-scoring system (biopsies) | ||||||
---|---|---|---|---|---|---|---|---|---|
 | Negative | Positive | p | Low | High | p | Low- risk | High- risk | p |
pT | Â | Â | 0.01 | Â | Â | 0.01 | Â | Â | 0.05 |
1.2 | 12 | 2 | Â | 12 | 2 | Â | 13 | 1 | Â |
3.4 | 15 | 17 | Â | 15 | 17 | Â | 21 | 11 | Â |
cDOI | Â | Â | 0.01 | Â | Â | 0.17 | Â | Â | 0.08 |
≤ 10 mm | 14 | 3 |  | 12 | 5 |  | 15 | 2 |  |
> 10 mm | 13 | 16 |  | 15 | 14 |  | 19 | 10 |  |
Lymph node metastasis | < 0.01 |  | < 0.01 |  | < 0.001 | ||||
(-) | 19 | 4 | Â | 19 | 4 | Â | 23 | 0 | Â |
(+) | 8 | 15 | Â | 8 | 15 | Â | 11 | 12 | Â |
pN |  |  | < 0.01 |  |  | 0.03 |  |  | < 0.001 |
0,1 | 23 | 9 | Â | 22 | 10 | Â | 28 | 4 | Â |
2,3 | 4 | 10 | Â | 5 | 9 | Â | 6 | 8 | Â |
ENE |  |  | < 0.001 |  |  | < 0.01 |  |  | < 0.001 |
(-) | 26 | 10 | Â | 25 | 11 | Â | 32 | 4 | Â |
(+) | 1 | 9 | Â | 2 | 8 | Â | 2 | 8 | Â |
Differentiation | Â | Â | 0.58 | Â | Â | 0.58 | Â | Â | 0.58 |
Well | 20 | 14 | Â | 14 | 14 | Â | 19 | 9 | Â |
Moderate | 6 | 5 | Â | 11 | 5 | Â | 13 | 3 | Â |
Poor | 1 | 0 | Â | 2 | 0 | Â | 2 | 0 | Â |
Invasion formation | Â | 0.11 | Â | Â | 0.45 | Â | Â | 0.28 | |
1.2 | 4 | 0 | Â | 3 | 1 | Â | 4 | 0 | Â |
3.4c.4d | 23 | 19 | Â | 24 | 18 | Â | 30 | 12 | Â |
DR | Â | 0.33 | Â | Â | 0.04 | Â | Â | 0.04 | |
Mature | 10 | 5 | Â | 12 | 3 | Â | 14 | 1 | Â |
Immature | 17 | 14 | Â | 15 | 16 | Â | 20 | 11 | Â |
TB | Â | 0.24 | Â | Â | 0.11 | Â | Â | 0.09 | |
Low | 14 | 7 | Â | 15 | 6 | Â | 18 | 3 | Â |
High | 13 | 12 | Â | 12 | 13 | Â | 16 | 9 | Â |
TILs | Â | 0.03 | Â | Â | 0.01 | Â | Â | 0.01 | |
High | 14 | 4 | Â | 15 | 3 | Â | 17 | 1 | Â |
Low | 13 | 15 | Â | 12 | 16 | Â | 17 | 11 | Â |